Citadel Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.15M | Buy |
1,123,746
+50,019
| +5% | +$453K | ﹤0.01% | 3379 |
|
|
2025
Q4 | $7.22M | Sell |
1,073,727
-212,145
| -16% | -$1.6M | ﹤0.01% | 3713 |
|
|
2025
Q3 | $11.1M | Buy |
1,285,872
+456,628
| +55% | +$3.55M | ﹤0.01% | 3116 |
|
|
2025
Q2 | $5.22M | Sell |
829,244
-838,473
| -50% | -$5.55M | ﹤0.01% | 4043 |
|
|
2025
Q1 | $10.7M | Buy |
1,667,717
+814,226
| +95% | +$6.73M | ﹤0.01% | 2771 |
|
|
2024
Q4 | $6.86M | Buy |
853,491
+289,446
| +51% | +$2.79M | ﹤0.01% | 3475 |
|
|
2024
Q3 | $7.12M | Sell |
564,045
-58,915
| -9% | -$761K | ﹤0.01% | 3405 |
|
|
2024
Q2 | $7.89M | Buy |
622,960
+332,309
| +114% | +$3.34M | ﹤0.01% | 3088 |
|
|
2024
Q1 | $1.39M | Buy |
+290,651
| New | +$1.35M | ﹤0.01% | 6246 |
|
|
2023
Q4 | – | Sell |
-10,970
| Closed | -$67.2K | – | 14930 |
|
|
2023
Q3 | $79.4K | Sell |
10,970
-74,215
| -87% | -$593K | ﹤0.01% | 11191 |
|
|
2023
Q2 | $633K | Buy |
85,185
+84,091
| +7,687% | +$661K | ﹤0.01% | 7424 |
|
|
2023
Q1 | $7.58K | Sell |
1,094
-368,053
| -100% | -$3.39M | ﹤0.01% | 13709 |
|
|
2022
Q4 | $3.79M | Sell |
369,147
-671,146
| -65% | -$11.8M | ﹤0.01% | 4338 |
|
|
2022
Q3 | $18.9M | Buy |
1,040,293
+351,134
| +51% | +$15.2M | ﹤0.01% | 1931 |
|
|
2022
Q2 | $35.4M | Buy |
689,159
+124,043
| +22% | +$6.43M | 0.01% | 1309 |
|
|
2022
Q1 | $41.6M | Buy |
565,116
+484,628
| +602% | +$43.2M | 0.01% | 1250 |
|
|
2021
Q4 | $11.5M | Sell |
80,488
-111,244
| -58% | -$19.1M | ﹤0.01% | 2831 |
|
|
2021
Q3 | $39.7M | Sell |
191,732
-491,736
| -72% | -$108M | 0.01% | 1308 |
|
|
2021
Q2 | $145M | Buy |
683,468
+326,732
| +92% | +$59.9M | 0.03% | 480 |
|
|
2021
Q1 | $64.7M | Sell |
356,736
-356,459
| -50% | -$71M | 0.02% | 841 |
|
|
2020
Q4 | $79.5M | Buy |
713,195
+389,536
| +120% | +$41.4M | 0.02% | 671 |
|
|
2020
Q3 | $35.1M | Sell |
323,659
-456,749
| -59% | -$55.6M | 0.01% | 1103 |
|
|
2020
Q2 | $65M | Buy |
780,408
+751,875
| +2,635% | +$28.8M | 0.02% | 634 |
|
|
2020
Q1 | $387K | Buy |
+28,533
| New | +$241K | ﹤0.01% | 6882 |
|
|
2019
Q4 | – | Sell |
-24,315
| Closed | -$105K | – | 9537 |
|
|
2019
Q3 | $122K | Buy |
+24,315
| New | +$133K | ﹤0.01% | 8392 |
|
|
2019
Q2 | – | Sell |
-280,362
| Closed | -$2.21M | – | 9641 |
|
|
2019
Q1 | $3.09M | Buy |
280,362
+218,601
| +354% | +$6.9M | ﹤0.01% | 3705 |
|
|
2018
Q4 | $2.27M | Buy |
61,761
+40,055
| +185% | +$1.55M | ﹤0.01% | 3946 |
|
|
2018
Q3 | $817K | Buy |
21,706
+2,917
| +16% | +$82.1K | ﹤0.01% | 5885 |
|
|
2018
Q2 | $504K | Buy |
18,789
+11,089
| +144% | +$375K | ﹤0.01% | 6356 |
|
|
2018
Q1 | $323K | Sell |
7,700
-64,225
| -89% | -$2.58M | ﹤0.01% | 6629 |
|
|
2017
Q4 | $1.78M | Buy |
71,925
+66,267
| +1,171% | +$1.62M | ﹤0.01% | 3792 |
|
|
2017
Q3 | $129K | Sell |
5,658
-12,259
| -68% | -$274K | ﹤0.01% | 6938 |
|
|
2017
Q2 | $412K | Buy |
17,917
+13,638
| +319% | +$268K | ﹤0.01% | 5404 |
|
|
2017
Q1 | $109K | Buy |
4,279
+2,820
| +193% | +$77.5K | ﹤0.01% | 6825 |
|
|
2016
Q4 | $37K | Sell |
1,459
-27,448
| -95% | -$801K | ﹤0.01% | 6935 |
|
|
2016
Q3 | $1.2M | Buy |
28,907
+26,954
| +1,380% | +$3.48M | ﹤0.01% | 3590 |
|
|
2016
Q2 | $284K | Buy |
1,953
+128
| +7% | +$14.7K | ﹤0.01% | 5297 |
|
|
2016
Q1 | $188K | Sell |
1,825
-113,244
| -98% | -$12.1M | ﹤0.01% | 5683 |
|
|
2015
Q4 | $19.3M | Buy |
115,069
+82,962
| +258% | +$12.8M | 0.02% | 862 |
|
|
2015
Q3 | $4.54M | Buy |
32,107
+10,460
| +48% | +$2.35M | ﹤0.01% | 2042 |
|
|
2015
Q2 | $4.82M | Buy |
21,647
+16,492
| +320% | +$2.9M | ﹤0.01% | 2101 |
|
|
2015
Q1 | $853K | Buy |
5,155
+2,301
| +81% | +$374K | ﹤0.01% | 4142 |
|
|
2014
Q4 | $338K | Sell |
2,854
-1
| -0% | -$105 | ﹤0.01% | 5254 |
|
|
2014
Q3 | $238K | Buy |
2,855
+136
| +5% | +$12.3K | ﹤0.01% | 5536 |
|
|
2014
Q2 | $251K | Sell |
2,719
-12,594
| -82% | -$1.11M | ﹤0.01% | 5295 |
|
|
2014
Q1 | $1.39M | Buy |
15,313
+10,961
| +252% | +$1.22M | ﹤0.01% | 3016 |
|
|
2013
Q4 | $445K | Buy |
4,352
+3,633
| +505% | +$257K | ﹤0.01% | 4159 |
|
|
2013
Q3 | $45K | Sell |
719
-313
| -30% | -$17.6K | ﹤0.01% | 5845 |
|
|
2013
Q2 | $42K | Buy |
+1,032
| New | +$44.7K | ﹤0.01% | 5748 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Citadel Advisors's NVAX Position: Q1 2026 in Review
Citadel Advisors increased its Novavax (NVAX) stake by 4.7% in Q1 2026, buying an estimated $453K and bringing the position to 1,123,746 shares worth $9.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3379.
Citadel Advisors first reported a position in NVAX in Q2 2013 and has held it in 49 quarters since. The position peaked at $145M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Citadel Advisors held 1,123,746 shares of Novavax worth $9.15M as of Q1 2026.
- Citadel Advisors bought 50,019 Novavax shares in Q1 2026, an estimated $453K.
- Novavax made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3379 holding.
- Citadel Advisors first reported a position in Novavax in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Novavax position peaked at $145M in Q2 2021.
- 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.